csestocks
Sona Nanotech (CSE:SONA,OTCQB:SNANF) is ramping up clinical trials for its targeted hyperthermia therapy (THT) for cancer. CEO David Regan said the company is looking forward to taking THT into in-human studies after interim results from its efficacy study on animals showed statistically significantly superior results. “We went into this study with a simple hypothesis that our THT for cancer would shrink cells and … tumors from the inside out … But we found something more interesting along the way,” he said. “We've seen in this study it’s not just that the treated tumor shrinks, but that you'r...
Investing News Network
Lancaster Resources (CSE:LCR,OTCQB:LANRF,FWB:6UF0) is gearing up to drill an exploration well at its Alkali Flat lithium brine project in New Mexico following the receipt of a technically complete letter from the New Mining and Minerals Division pertaining to its permit application. “Hopefully we can get started within the next 30 to 60 days,” said CEO Penny White. “Basically we'll be doing our exploratory well, which is really just a drill that will go down about 700 meters. And what we'll be able to do is explore that to really interesting targets that we've delineated through all of our exp...
Investing News Network
閲覧を続けるには、ノアドット株式会社が「プライバシーポリシー」に定める「アクセスデータ」を取得することを含む「nor.利用規約」に同意する必要があります。
「これは何?」という方はこちら